(EMAILWIRE.COM, December 08, 2008 ) SAN DIEGO, CA, December 8, 2008 -- US Farms, Inc. (OTCBB: USFM), a diversified commercial farming and nursery company today announced that it has signed a non-exclusive Letter of Intent to acquire Phytoceutical Inc. of San Diego, California. This acquisition, once completed, will allow US Farms, Inc. to enter into the growing, manufacturing, marketing and sales of Epilobium based consumer products. US Farms, Inc. will begin production on the Epilobium herb at its Southern California greenhouse facilities effective immediately. This transaction is subject to continued due diligence and has a 90 day closing period.

Epilobium is not a new herb. It has been celebrated for its health successes throughout Europe for decades, and has just recently been “rediscovered” as a potent treatment for a variety of male and female maladies. Attention was originally focused on Epilobium for its beneficial effects regarding prostate health for men, and urinary tract health for women. The use of Epilobium (Family Onagraceae) was widespread in Central and Eastern Europe as well as in certain areas of North America for centuries to treat these maladies. This pleasant herb, used as a tea, was first highly recommended by Austrian herbalist, Maria Treben, for ailing men who were suffering with prostate abnormalities. Epilobium has been and continues to be the subject of numerous studies throughout Europe. Upon further study, it was learned that Epilobium is far more potent than Saw Palmetto and has similar, yet more powerful effects for blocking dihydrotestosterone (DHT), the common cause of enlarged prostate and hair loss.

In traditional herbal medicine, Epilobium had proven to have antibacterial, anti-inflammatory, antimicrobial and antioxidant properties. It has been used successfully for bladder health maintenance, male health maintenance, hormonal imbalances, and urinary system health.

In 2003, The Journal of Pharmacy and Pharmacology published results of an Epilobium-relevant study led by Annabella Vitalone, PhD. The study specifically addresses the use of Epilobium in treating benign prostate hyperplasia (BPH). A non-cancerous enlargement of the prostate gland, BPH is generally considered to be a normal part of the male aging process with cell proliferation traced to age-related changes in hormone balance and cell-growth factors.


In this transaction, US Farms, Inc. will be acquiring 100% of the stock issued and outstanding of Phytoceutical, Inc.
Bob Jacquet, CEO of Phytoceutical, Inc. commented, “We are very pleased to be working with US Farms, Inc and its management team. The infrastructure that US Farms, Inc. brings to the table with its greenhouses and farming facilities in place, only enhances the big picture in terms of our larger scale growing capacity of the Epilobium herb and also to aggressively move the sales and marketing side of our Epilobium based products to the next level.”
Yan K. Skwara, CEO of US Farms, Inc. stated, “When consummated, this transaction will enable US Farms, Inc. to leverage its current farming and nursery operations into a vertically integrated player in the $4 billion US market for BPH products. Growing multiple plants, crops and herbs and turning those products into a final end product for consumers is our cookie cutter process that we will continue to build on as we enter the 2009 campaign. In the past few years, we have shown what can be done with Aloe Vera crop and now with the Epilobium herb, we can certainly enhance our fundamental business while continuing to vertically integrate to increase our future sales and earnings.
About Phytoceutical, Inc.

Phytoceutical, Inc. is headquartered in San Diego, California and since 2006, its corporate purpose is to develop, manufacture and market “lifestyle pharmaceutical” products. The company’s mission is to be the leading provider of over-the-counter (OTC) Epilobium-based “lifestyle pharmaceutical” products by providing the highest efficacy rate with no known side effects.

Phytoceutical, Inc. has positioned itself on the cutting edge of research for Epilobium and has developed a strong foundation for its intellectual property.
For more information on Phytoceutical, Inc., please visit http://www.epilobium.com.



About US Farms, Inc.

US Farms, Inc. is a diversified commercial Farming and Nursery company. The company currently grows, markets and distributes horticultural products through a number of its wholly owned subsidiaries. US Farms, Inc. is currently one of the largest domestic growers of Aloe Vera, growing well over 6 million pounds annually. The company plans to further its vertically integrating path by moving into the marketing and sales of Aloe Vera based products. The company's products are sold through supermarkets, home centers, retail merchandisers, garden centers, mail order, direct sales, re-wholesalers, and landscapers throughout the United States and Canada. Through internal growth and strategic acquisitions the company is expanding its market share in its businesses.
For more information on US Farms, Inc., please visit http://www.usfarmsinc.com. US Farms, Inc. is publicly traded on the over-the-counter market under the ticker symbol USFM.OB


Safe Harbor

This press release contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made and involve a number of risks and uncertainties, including, but not limited to, our ability to produce and market a Nutricutical Aloe Vera based energy supplement in the United States; acceptance by the market of an Aloe Vera nutricutical supplement; continued popularity of the energy drink marketplace; the continued production of Aloe Vera products; the Company's ability to develop an energy drink from a whole food source; the expansion and growth of farming and nursery products; ability to raise additional capital; the impact of competitive products; product demand; fluctuations in operating results and other risks detailed from time to time in US Farms, Inc.'s filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. US Farms undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


Contact:
US Farms, Inc.
Tel: 858-488-7775 ext 102
Fax: 858-488-2828

Investor Relations
Jamie Dryer
Flagler Communications
561-837-8057
http://www.otcfn.com/usfm

www.energyaloe.com/

About StockProfit.com

StockProfit.com specializes in using technical analysis to identify stocks in particularly powerful up-trends, then pinpoint the optimal time to enter these stocks. Additionally, StockProfit.com is an online resource for aggressive risk-tolerant market participants who wish to learn about select growth companies and other ideas that could offer potentially superior investment returns. Research and due diligence tools such as Company Profiles, Technical Trading Alerts, detailed investment opinion reports, and regular email updates of Featured Companies are some of the services we provide to our readership. For more information, visit http://www.stockprofit.com


Disclaimer: Copyright 2008 StockProfit. All rights reserved. StockProfit is an independent electronic publication providing information on select public companies. Majority of the companies featured by StockProfit pay consideration in cash and/or stock for electronic dissemination and advertisement of company information. StockProfit is not a registered investment advisor or broker-dealer. This update is provided as an information service only, and the statements and opinions in this update should not be construed as an offer or solicitation to buy or to sell any security. In no event shall StockProfit and/or its publisher, Stock Services LLC, or any of its employees or affiliates, be liable for any direct, incidental, consequential, indirect, or punitive damages whatsoever arising out of the use of the information, or for any errors or omissions in the content thereof, including, but not limited to, from any investment loss, damage, or expense incurred by any investor resulting from the information, or from the purchase or sale of any profiled company. We have been compensated two hundred and sixty thousand Rule 144 shares of USFM common stock for publication and electronic dissemination of company information. For our full disclaimer, please visit http://www.stockprofit.com/disclaimer.html. An investment in USFM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. This update may contain forward-looking statements, which involve risk, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Fur further details concerning these risks and uncertainties, please see the SEC filings, if any, on USFM including the company's most recent annual and quarterly reports.

CONTACT: Alan Klitenic, Stock Services LLC, TEL: 818 334 4469 EMAIL: amk@stockprofit.com

Contact Information:
P.A. Relations
Alan Klitenic
Tel: 818-334-4469
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.